DexCom Inc - Company Profile
Powered by 
All the sales intelligence you need on DexCom Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how DexCom Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with DexCom Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Dexcom Inc (Dexcom) is a medical device company focused on the design, development, and commercialization of continuous glucose monitoring (CGM) systems. Its major products include the Dexcom G7 and G6 integrated CGM systems, Dexcom Share remote monitoring system, Dexcom Real-Time API, Dexcom ONE CGM system, associated software, mobile apps, and Stelo Glucose Biosensor. The company also provides Dexcom Care training to users of the CGM system and other support services. It offers products to endocrinologists, physicians, diabetes educators, and others in the US, Austria, Canada, Germany, Switzerland, and the UK, and through distributors in Australia, the US, New Zealand, and other countries in Asia, Europe, Africa, Latin America, and the Middle East. Dexcom is headquartered in San Diego, California, the US.
Headquarters
United States of America
Address
6340 Sequence Drive, San Diego, California, 92121
Website
www.dexcom.com
Telephone
1 858 2000200
No of Employees
11,000
Industry
Medical Equipment
Ticker Symbol & Exchange
DXCM (NASD)
Revenue (2024)
$4.7B
15.6%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
45.1%
(2024 vs 2023)
Market Cap*
$26.0B
Net Profit Margin (2024)
XYZ
25.5%
(2024 vs 2023)
* As of and is in US$
DexCom Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| CGM System | Support | DexCom G6 |
| Share System | Training | DexCom Share |
| Real-Time API | Dexcom G7 | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Plans/Strategy | In February, the company announced its plans to launch an advanced AI-enabled enhancement to Stelo. |
| 2025 | New Products/Services | In December, the company announced the launch of Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes. |
| 2025 | New Products/Services | In December, the company launched Dexcom Academy, a personalized learning platform. |
Competitor Comparison
| Key Parameters | DexCom Inc | Abbott Laboratories | Medtronic Plc | Becton Dickinson and Co | Ascensia Diabetes Care US Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Ireland | United States of America | United States of America |
| City | San Diego | Abbott Park | Dublin | Franklin Lakes | Parsippany |
| State/Province | California | Illinois | - | New Jersey | New Jersey |
| No. of Employees | 11,000 | 115,000 | 95,000 | 72,000 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Kevin R. Sayer | Chairman | Executive Board | 2018 | 68 |
| Jacob S. Leach | Chief Executive Officer; President; Director | Executive Board | 2026 | 48 |
| Jereme M. Sylvain | Chief Financial Officer; Executive Vice President | Senior Management | 2021 | 46 |
| Peter C. Simpson | Executive Vice President; Chief Technology Officer | Senior Management | 2023 | - |
| Michael Brown | Executive Vice President; Chief Legal Officer | Senior Management | 2022 | 56 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer